BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 19519205)

  • 1. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary factors in pancreatic cancer.
    Lynch HT; Brand RE; Lynch JF; Fusaro RM; Kern SE
    J Hepatobiliary Pancreat Surg; 2002; 9(1):12-31. PubMed ID: 12021894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for screening for pancreatic adenocarcinoma in high-risk patients.
    Canto MI
    Semin Oncol; 2007 Aug; 34(4):295-302. PubMed ID: 17674957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer screening: state of the art.
    Gemmel C; Eickhoff A; Helmstädter L; Riemann JF
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):89-96. PubMed ID: 19210116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis of pancreatic cancer.
    Brand R
    Cancer J; 2001; 7(4):287-97. PubMed ID: 11561605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients].
    Béchade D
    Bull Cancer; 2011 Jul; 98(7):827-36. PubMed ID: 21684836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options.
    Pausawasdi N; Scheiman J
    Curr Opin Gastroenterol; 2007 Sep; 23(5):515-21. PubMed ID: 17762557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology.
    Märten A; Büchler MW; Werft W; Wente MN; Kirschfink M; Schmidt J
    J Immunother; 2010; 33(2):219-24. PubMed ID: 20139773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection and staging of adenocarcinoma of the pancreas.
    Pappas S; Federle MP; Lokshin AE; Zeh HJ
    Gastroenterol Clin North Am; 2007 Jun; 36(2):413-29, x. PubMed ID: 17533087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic approach to pancreatic adenocarcinoma.
    Germanos S; Gourgiotis S; Stavrothanasopoulou A; Alepas P; Zampitis N; Panteli A
    J Gastrointestin Liver Dis; 2006 Sep; 15(3):257-63. PubMed ID: 17013451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.
    Larghi A; Verna EC; Lecca PG; Costamagna G
    Clin Cancer Res; 2009 Mar; 15(6):1907-14. PubMed ID: 19276278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of gene expression profiling of pancreatic cancer.
    Goonetilleke KS; Siriwardena AK
    Int J Surg; 2008 Feb; 6(1):81-3. PubMed ID: 18359465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early diagnosis and staging of pancreatic cancer].
    Shiratori K
    Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):164-7. PubMed ID: 16878407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the diagnosis and treatment of pancreatic cancer--the Kyoto University experience.
    Manabe T; Tobe T
    Hepatogastroenterology; 1989 Dec; 36(6):431-6. PubMed ID: 2693297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary pancreatitis and secondary screening for early pancreatic cancer.
    Vitone LJ; Greenhalf W; Howes NR; Neoptolemos JP
    Rocz Akad Med Bialymst; 2005; 50():73-84. PubMed ID: 16358943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and surveillance approaches in familial pancreatic cancer.
    Canto MI
    Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):535-53, x. PubMed ID: 18674702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial pancreatic cancer: a review.
    Lynch HT; Smyrk T; Kern SE; Hruban RH; Lightdale CJ; Lemon SJ; Lynch JF; Fusaro LR; Fusaro RM; Ghadirian P
    Semin Oncol; 1996 Apr; 23(2):251-75. PubMed ID: 8623061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum tumor markers at exocrine adenocarcinoma of pancreas].
    Holubec L; Finek J; Topolcan O; Svobodová S
    Cas Lek Cesk; 2005; 144(2):86-8; discussion 89. PubMed ID: 15807292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer: diagnosis and management.
    Freelove R; Walling AD
    Am Fam Physician; 2006 Feb; 73(3):485-92. PubMed ID: 16477897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.